Zai Lab (ZLAB) Retained Earnings (2016 - 2026)
Zai Lab (ZLAB) posted quarterly Retained Earnings of -$2.7 billion for Q1 2026, down 7.12% year-on-year from -$2.9 billion in Q1 2025, and down 1.94% on a QoQ basis from -$2.6 billion in Q4 2025.
Zai Lab (ZLAB) Retained Earnings (2016 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Retained Earnings for 11 consecutive years, with -$2.7 billion the latest figure, recorded in Q1 2026.
- Quarterly Retained Earnings fell 7.12% year-over-year to -$2.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.7 billion (down 7.12% YoY) and the FY2025 annual result came in at -$2.6 billion, down 7.16% from the prior year.
- Retained Earnings fell to -$2.7 billion in Q1 2026 per ZLAB's latest filing, from -$2.6 billion in the prior quarter.
- Over the last five years, Retained Earnings for ZLAB reached as high as -$1.5 billion in Q1 2022 and fell as low as -$2.7 billion in Q1 2026.
- A 5-year average of -$2.2 billion and a median of -$2.2 billion in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings plunged 58.53% — and 2026, when it fell 7.12%.
- Year by year, Retained Earnings stood at -$1.9 billion in 2022, then decreased by 17.98% to -$2.2 billion in 2023, then decreased by 11.71% to -$2.5 billion in 2024, then dropped by 7.16% to -$2.6 billion in 2025, then decreased by 1.94% to -$2.7 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$2.7 billion, -$2.6 billion, and -$2.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | -2.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.68 Bn |
| Dec 31, 2025 | -2.63 Bn |
| Sep 30, 2025 | -2.58 Bn |
| Jun 30, 2025 | -2.54 Bn |
| Mar 31, 2025 | -2.50 Bn |
| Dec 31, 2024 | -2.45 Bn |
| Sep 30, 2024 | -2.37 Bn |
| Jun 30, 2024 | -2.33 Bn |
| Mar 31, 2024 | -2.25 Bn |
| Dec 31, 2023 | -2.20 Bn |
| Sep 30, 2023 | -2.10 Bn |
| Jun 30, 2023 | -2.03 Bn |
| Mar 31, 2023 | -1.91 Bn |
| Dec 31, 2022 | -1.86 Bn |
| Sep 30, 2022 | -1.80 Bn |
| Jun 30, 2022 | -1.64 Bn |
| Mar 31, 2022 | -1.50 Bn |
| Dec 31, 2021 | -1.42 Bn |
| Sep 30, 2021 | -1.21 Bn |
| Jun 30, 2021 | -1.11 Bn |